Cytomedix  
表面皮肤烧伤通过自体血小板凝胶敷料的愈合

Cytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet technologies for orthopedics and wound care, with a pipeline of adult stem cell therapies for tissue repair. The Company markets the AutoloGelTM System, a device for the production of autologous platelet rich plasma (“PRP”) gel for use on a variety of exuding wounds, and the Angel® Whole Blood Separation System, a blood processing device and disposable products used for the separation of whole blood into red cells, platelet poor plasma (“PPP”) and PRP for use in surgical and orthopedic settings. Our development pipeline of autologous regenerative cell therapies utilizes proprietary ALDH Bright Cell ("ALDHbr") technology to isolate biologically active pluri-potent stem cells for therapeutic use. A Phase 2 trial for the treatment of ischemic stroke using our ALDHbr Bright Cells is underway.